Hyperbaric Chamber Benefits: What the Evidence Shows

Hyperbaric chamber benefits are increasingly discussed in the context of bariatric and weight management care, but understanding what the evidence actually supports is essential before pursuing treatment. Hyperbaric oxygen therapy (HBOT) involves breathing pure oxygen inside a pressurised enclosure, and it has a well-established role in specific NHS-commissioned conditions. This article explains how HBOT works, what the current UK evidence shows, whether it has any role after bariatric surgery, what risks to be aware of, and how to access treatment safely through the NHS or a regulated private provider.

What is a hyperbaric chamber and how does it work?

A hyperbaric chamber pressurises oxygen to 1.5 to 3.0 ATA, allowing it to dissolve directly into blood plasma and deliver higher oxygen concentrations to tissues, promoting repair, reducing inflammation, and supporting angiogenesis.

A hyperbaric chamber is a sealed, pressurised enclosure in which a person breathes pure oxygen at atmospheric pressures higher than those found at sea level, typically between 1.5 and 3.0 atmospheres absolute (ATA). Under these conditions, oxygen dissolves directly into the blood plasma rather than relying solely on haemoglobin, allowing tissues throughout the body to receive significantly higher concentrations of oxygen than they would under normal breathing conditions.

The therapy is known as hyperbaric oxygen therapy (HBOT). Sessions usually last between 60 and 90 minutes, during which the patient sits or lies inside a monoplace (single-person) or multiplace (multi-person) chamber. In monoplace chambers the entire enclosure is filled with oxygen; in multiplace chambers, patients breathe oxygen through a close-fitting hood or mask at pressure, while the chamber itself is pressurised with air.^[1] The increased oxygen tension is thought to promote tissue repair, reduce inflammation, and support the growth of new blood vessels, a process called angiogenesis.

HBOT has a well-established role in treating specific medical conditions. NHS England commissions it for indications including decompression illness, arterial gas embolism, carbon monoxide poisoning, and certain non-healing wounds such as diabetic foot ulcers that have not responded to standard care.^[1][2] Outside these commissioned indications, HBOT is also offered privately for a broader range of conditions, though the evidence base varies considerably depending on the application.

It is important to distinguish between medically supervised HBOT delivered in a clinical setting and the lower-pressure wellness chambers increasingly available in gyms and spas. These devices typically operate at pressures below 1.3 ATA and are not equivalent to clinical HBOT. Therapeutic claims made for low-pressure wellness chambers are not supported by the same body of evidence as clinical HBOT, and patients should interpret such claims with caution.

Can hyperbaric oxygen therapy support weight loss after bariatric surgery?

There is no robust evidence that HBOT directly causes weight loss after bariatric surgery; its limited post-operative role is restricted to specialist wound healing in high-risk patients, decided case by case.

There is currently no robust clinical evidence that hyperbaric oxygen therapy directly causes weight loss or meaningfully accelerates weight reduction following bariatric surgery. The two interventions address different physiological mechanisms: bariatric procedures such as gastric bypass or sleeve gastrectomy work by restricting caloric intake and altering gut hormone signalling, whereas HBOT acts primarily on tissue oxygenation and repair.

Where HBOT may have a supporting role after bariatric surgery is in wound healing. Bariatric patients, particularly those with obesity-related comorbidities such as type 2 diabetes or peripheral vascular disease, can be at increased risk of poor wound healing following surgery. In these specific circumstances, HBOT has been used as an adjunct to promote healing of surgical wounds or anastomotic complications. This use is highly specialist, non-routine, and is typically considered only after standard wound care has not achieved adequate results; it remains a decision made on a case-by-case basis by the treating surgical team.

Some proponents suggest that improved oxygenation may support energy metabolism or reduce post-operative fatigue, potentially helping patients engage more readily with physical rehabilitation. However, these proposed benefits have not been confirmed in well-designed randomised controlled trials in the bariatric population specifically, and NICE has not issued guidance recommending HBOT as part of post-bariatric care pathways.

Patients considering HBOT alongside or after bariatric surgery should discuss this with their bariatric surgical team before proceeding. The priority after bariatric surgery remains adherence to dietary guidance, nutritional supplementation, and gradual physical activity, all of which have a strong evidence base for supporting long-term outcomes. HBOT should not be viewed as a substitute for these established components of post-operative care.

What does the evidence say about hyperbaric therapy benefits in the UK?

NHS evidence supports HBOT for decompression illness, gas embolism, carbon monoxide poisoning, and selected non-healing wounds; evidence for wellness, fatigue, or weight management does not meet NHS commissioning thresholds.

The evidence for HBOT is strongest for a defined set of conditions, and NHS commissioning reflects this selectivity. NHS England commissions HBOT for decompression illness, arterial gas embolism, carbon monoxide poisoning, and certain chronic non-healing wounds, including diabetic foot ulcers that have not responded to standard care.^[1][2] Access depends on the specific indication, local Integrated Care Board (ICB) commissioning arrangements, and specialist assessment. For these indications, the evidence from clinical trials and systematic reviews is considered sufficient to justify routine use.

Beyond these established indications, the evidence picture is more mixed. NICE has reviewed HBOT for conditions including multiple sclerosis, radiation-induced tissue damage (such as late effects of radiotherapy to the pelvis or head and neck), and refractory osteomyelitis. For radiation-induced tissue injury, NICE interventional procedures guidance acknowledges that HBOT may be beneficial in selected patients, but recommends it is used only in specialist centres with appropriate governance arrangements.^[3]

For applications such as general wellness, fatigue, cognitive enhancement, or weight management, the current evidence does not meet the threshold required for NHS commissioning or a positive NICE recommendation. Many studies in these areas are small, lack control groups, or have not been replicated in larger trials. Patients should be cautious about claims that go beyond what the published literature supports.

The British Hyperbaric Association (BHA) maintains a directory of HBOT facilities in the UK and can be a useful starting point for patients seeking information about evidence-based applications. When evaluating any HBOT provider, it is reasonable to ask which specific indication is being treated, what evidence supports that use, and whether the facility operates under appropriate clinical governance.

Are there any risks or side effects I should know about?

The most common risk is ear and sinus barotrauma during pressurisation; rarer but serious risks include pulmonary oxygen toxicity and seizures, with HBOT contraindicated in untreated pneumothorax.

Hyperbaric oxygen therapy is generally well tolerated when delivered in an accredited clinical setting, but it does carry recognised risks and side effects that patients should understand before starting treatment. The most common side effect is barotrauma, which refers to pressure-related injury to air-filled spaces in the body. This most frequently affects the ears and sinuses, causing discomfort or pain during pressurisation, similar to the sensation experienced when descending in an aircraft. Patients are taught equalisation techniques to manage this.

Oxygen toxicity is a more serious but less common risk, particularly affecting the lungs (pulmonary oxygen toxicity) with prolonged or repeated high-pressure exposures, and in rare cases the central nervous system, which can cause seizures. Clinical HBOT protocols are designed to minimise this risk through careful pressure and duration limits, and seizures are uncommon when treatment is delivered within established guidelines.

Other potential side effects include temporary changes in vision (myopia), claustrophobia in monoplace chambers, and, rarely, fire risk given the oxygen-enriched environment. Reputable facilities have strict safety protocols to address this.

HBOT is contraindicated in patients with an untreated pneumothorax. It should be used with caution in people with certain lung conditions, a history of ear surgery, or those taking specific medications such as bleomycin or doxorubicin. Patients who are pregnant or breastfeeding should seek specialist advice before undergoing HBOT, as the risk-benefit assessment may differ depending on the indication. Patients with implanted devices, including pacemakers, insulin pumps, or cochlear implants, should confirm HBOT compatibility with the device manufacturer or the team who implanted the device before proceeding.

If you experience ear pain, visual disturbance, chest tightness, or any unusual symptoms during or after a session, inform the clinical team immediately. For non-urgent concerns following a session, contact your GP. If you experience severe chest pain or difficulty breathing, call 999. Suspected side effects from any medicine used alongside HBOT can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

How do I access hyperbaric oxygen therapy through the NHS or privately?

NHS HBOT requires a specialist referral for commissioned indications; private providers should be CQC-registered in England and affiliated with the British Hyperbaric Association.

NHS access to HBOT is available for commissioned indications and requires a referral from a specialist, typically a consultant in the relevant field such as a vascular surgeon, diabetologist, or oncologist. NHS HBOT is delivered at a small number of specialist centres across the UK, and your local Integrated Care Board (ICB) determines which services are commissioned in your area. Patients cannot self-refer for NHS HBOT, and access for non-commissioned indications is not routinely available through the NHS.

For private access, HBOT is offered at a growing number of independent clinics and some charitable facilities, including those run by Multiple Sclerosis therapy centres, which have provided HBOT to their members for several decades.^[7] Private costs vary depending on the number of sessions required and the clinical indication, and patients should request a clear breakdown of fees before committing to a course of treatment.

When choosing a private HBOT provider, it is advisable to check that the facility is staffed by appropriately trained clinicians, operates under a recognised clinical governance framework, and is listed with or affiliated to the British Hyperbaric Association. In England, independent healthcare providers offering HBOT that deliver regulated activities are required to be registered with the Care Quality Commission (CQC); in Scotland, Healthcare Improvement Scotland carries out this function; in Wales, Healthcare Inspectorate Wales; and in Northern Ireland, the Regulation and Quality Improvement Authority (RQIA). Checking the relevant register for your nation is a practical step before proceeding.

If you are considering HBOT as part of a broader weight management plan, your GP is the appropriate first point of contact. They can advise on whether HBOT is clinically indicated for your circumstances and refer you to appropriate NHS or specialist services. Weight management options, including clinically supervised programmes, should be explored through your GP or a specialist weight management service in the first instance.

Scientific References

1. Reviewing Hyperbaric Oxygen Services: Consultation Guide.
2. Appendix A4: Summary of evidence from surveillance (NG28).
3. About interventional procedures guidance.
4. Seizures during hyperbaric oxygen therapy.
5. Nuclear cataract and myopia during hyperbaric oxygen therapy.
6. Seizure frequency in more than 180,000 treatment sessions with hyperbaric oxygen therapy - a single centre 20-year analysis.
7. Hyperbaric oxygen therapy for multiple sclerosis.
8. EMA guidance on use of medicinal products in treatment in case of exposure to chemical agents used as weapons of terrorism, crime or warfare.

Frequently Asked Questions